Obesity Is Associated with Changes in Laboratory Biomarkers in Chilean Patients Hospitalized with COVID-19

Simple item page
datacite.alternateIdentifier.citationJOURNAL OF CLINICAL MEDICINE,Vol.12,2023
datacite.alternateIdentifier.doi10.3390/jcm12103392
datacite.creatorViscardi, Sharon
datacite.creatorMarileo, Luis
datacite.creatorDelgado, Hugo
datacite.creatorSan Martin, Andres
datacite.creatorHernandez, Loreto
datacite.creatorGarces, Paola
datacite.creatorGuzman Oyarzo, Dina
datacite.creatorBoguen, Rodrigo
datacite.creatorMedina, Gustavo
datacite.creatorLetelier, Pablo
datacite.creatorVillano, Ines
datacite.creatorGuzman, Neftali
datacite.date2023
datacite.subject.englishCOVID-19
datacite.subject.englishSARS-CoV-2
datacite.subject.englishobesity
datacite.subject.englishlaboratory markers
datacite.titleObesity Is Associated with Changes in Laboratory Biomarkers in Chilean Patients Hospitalized with COVID-19
dc.date.accessioned2023-06-27T13:13:33Z
dc.date.available2023-06-27T13:13:33Z
dc.description.abstractBackground and aims: It is reported that patients with obesity are more frequently hospitalized for COVID-19, and evidence exists that obesity is a risk factor, regardless of other comorbidities. The objective of this study was to evaluate the association of obesity with changes in laboratory biomarkers in hospitalized Chilean patients. Materials and methods: A total of 202 hospitalized patients (71 with obesity and 131 without obesity) with a diagnosis of COVID-19 were included in the study. Demographic, clinical, and laboratory (days 1, 3, 7, 15) data were obtained. We performed a statistical analysis, assuming significance with a value of p < 0.05. Results: Significant differences in chronic respiratory pathology are observed between patients with and without obesity. The inflammatory markers CPR, ferritin, NLR, and PLR are elevated during the evaluated period, while changes in leukocyte populations are present on day 1 (eosinophils) and day 3 (lymphocytes). Finally, a persistent elevation of D-dimer level is observed, presenting significant differences on day 7 between patients with and without obesity. Obesity had a positive correlation with admission to the critical patient unit, invasive mechanical ventilation, and length of hospital stay. Conclusion: Patients with obesity hospitalized for COVID-19 present marked elevations of inflammatory and hemostasis parameters, with a correlation between obesity, changes in laboratory biomarkers, and the risk of adverse clinical outcomes also observed.
dc.identifier.urihttps://repositoriodigital.uct.cl/handle/10925/5374
dc.language.isoen
dc.publisherMDPI
dc.sourceJOURNAL OF CLINICAL MEDICINE
oaire.resourceTypeArticle
uct.indizacionSCI
Files
Collections
MigraciĆ³n Web of Science